DOCSLIB.ORG

Keynote Lecture Opening Ceremony Plenary Lecture

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Keynote Lecture Opening Ceremony Plenary Lecture 467 Opening Ceremony/ Keynote Lecture/ Keynote Lecture Plenary Lecture Keynote Lecture p.523 Thursday, September 17, 16:00～17:00 (JST) Live Streaming KL Molecular targeting of Treg cells for controlling immune responses Chair: Motohiro Ebisawa Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan Speaker: Shimon Sakaguchi Department of Experimental Immunology, WPI Immunology Frontier Research Center, Osaka University, Japan Opening Ceremony Opening Ceremony p.524 Thursday, September 17, 17:00～18:30 (JST) Live Streaming A Special Tribute to Dr. Kimishige Ishizaka and Dr. Teruko Ishizaka Chairs: Motohiro Ebisawa Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan Yuji Tohda Department of Respiratory Medicine and Allergology, Kindai University, Faculty of Medicine, Japan Continuing impact of the discovery of IgE by the Ishizakas Speaker: Hirohisa Saito National Research Institute for Child Health & Development, Japan Dr. Kimishige Ishizaka's recorded presentation “Identification of immunoglobulin E” Speaker: Kimishige Ishizaka (1925-2018) La Jolla Institute for Allergy and Immunology, USA Special Message from Prof. Terumasa Miyamoto Speaker: Terumasa Miyamoto The University of Tokyo, Japan Plenary Lecture Plenary Lecture 1 p.526 Immunotherapy PL-1-1 Sublingual immunotherapy and anti-IgE therapy for Japanese cedar pollinosis in Japan Speaker: Kimihiro Okubo Department of Otolaryngology, Nippon Medical School, Japan PL-1-2 Allergen Immunotherapy (AIT) in asthma Speaker: Ignacio J Ansotegui Department of Allergy & Immunology, Hospital Quironsalud Bizkaia, Spain PL-1-3 Feld 1-specific IgG4 antibodies: biologicals for cat allergy Speaker: Mohamed Shamji Imperial College London National Heart and Lung Institute; Asthma UK Centre in Allergic Mechanisms of Asthma, UK Plenary Lecture 2 p.527 Skin Allergy PL-2-1 Insights into chronic urticaria for diagnosis and management Speaker: Michihiro Hide Department of Dermatology, Hiroshima University, Japan PL-2-2 Hereditary angioedema (HAE) Speaker: Marcus Maurer Department of Dermatology & Allergy, Charité-Universitätsmedizin Berlin, Germany PL-2-3 Atopic eczema - is the epithelium the problem? Speaker: Lisa A Beck Dermatology, Medicine and Pathology, University of Rochester Medical Center, USA DOUSBLQGG 468 Plenary Lecture 3 p.528 Food Allergy PL-3-1 Management of food allergy in Japan Speaker: Motohiro Ebisawa Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Japan PL-3-2 Food allergy: current and future treatment Speaker: Hugh A Sampson Department of Pediatrics, Icahn School of Medicine at Mount Sinai, USA Plenary Lecture PL-3-3 Adjuvants and OIT Speaker: Mimi Tang Department of Allergy Immunology, Murdoch Children's Research Institute (MCRI), Australia Plenary Lecture 4 p.529 Basic Science PL-4-1 Regulation of allergic responses to food by intestinal bacteria Speaker: Cathryn Rose Nagler Department of Pathology, Biological Sciences Division and Pritzker School of Molecular Engineering, The University of Chicago, USA PL-4-2 Group 2 innate lymphoid cells regulate susceptibility to allergic disorders Speaker: Kazuyo Moro Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University School of Medicine; Laboratory for Innate Immune Systems, RIKEN-IMS, Japan PL-4-3 The epithelial barrier hypothesis for the development of allergic and autoimmune diseases Speaker: Cezmi A Akdis Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Christine Kühne- Center for Allergy Research and Education (CK-CARE), Switzerland Plenary Lecture 5 p.530 Environmental Factors PL-5-1 The impact of climate change on pollen allergy and forecast system for allergenic pollen in future Speaker: Jae-Won Oh Department of Pediatrics, College of Medicine, Division of Allergy and Respiratory Diseases, Hanyang University, Guri Hospital, Republic of Korea PL-5-2 The allergenic activity of mites and fungi IgE-binding components Speaker: Luis Caraballo Institute for Immunological Research, University of Cartagena, Colombia PL-5-3 Environmental factors on airway and allergic disease: air pollution and global warming Speaker: David Blaine Peden Department of Pediatrics and Center for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, USA Plenary Lecture 6 p.531 Eosinophils and Related Diseases PL-6-1 Mechanisms of eosinophilic inflammation Speaker: Makoto Nagata Department of Respiratory Medicine/Allergy Center, Saitama Medical University, Japan PL-6-2 Eosinophils and eosinophil-related diseases Speaker: Robert Schleimer Allergy and Immunology, Northwestern University Feinberg School of Medicine, USA PL-6-3 Eosinophilic gastrointestinal diseases-clinical manifestations and therapeutic options Speaker: Glenn Furuta Department of Pediatrics, University of Colorado School of Medicine/Children's Hospital Colorado, USA Plenary Lecture 7 p.532 Severe Asthma PL-7-1 Mechanism of severe asthma (Tentative) Speaker: Giorgio Walter Canonica Internal Medicine, Humanitas University & Research Hospital, Italy PL-7-2 Biomarkers of severe asthma (SA): lessons from longitudinal cohorts Speaker: Hae-Sim Park Department of Allergy & Clinical Immunology, Ajou University Medical Center, Republic of Korea PL-7-3 Treatment of severe asthma Speaker: Sally E Wenzel Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, USA DOUSBLQGG 469 Plenary Lecture 8 p.533 Prevention PL-8-1 Basic concept about primary prevention of allergic diseases Speaker: Hirohisa Saito National Research Institute for Child Health & Development, Japan PL-8-2 Allergy prevention Speaker: Harald Renz Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg; University Hospital Giessen and Marburg GmbH, Germany PL-8-3 Prevention of atopic dermatitis and food allergy (Tentative) Speaker: George Du Toit Paediatric Allergy, Kings College London, School of Life Course Sciences and School of Immunology & Microbial Sciences, UK Symposium Plenary Lecture/ Symposium Symposium 1 p.534 Severe Asthma SY-1(I-1)-1 How close are we to precision medicine for severe/difficult to treat asthma? Speaker: Hisako Matsumoto Department of Respiratory Medicine, Graduate School of Medicine Kyoto University, Japan SY-1(I-1)-2 Phenotypes of severe asthma Speaker: Sang Heon Cho Department of Internal Medicine, Seoul National University College of Medicine, Republic of Korea SY-1(I-1)-3 Biology meets biologics: severe asthma treatment in 2020 Speaker: Sally E Wenzel Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, USA Symposium 2 p.535 Prevention of Allergy SY-2(P-1)-1 Environmental exposures and life-course trajectories of allergic diseases Speaker: Adnan Custovic National Heart and Lung Institute, Imperial College London, UK SY-2(P-1)-2 Allergy prevention by combatting skin sensitization Speaker: Yukihiro Ohya Allergy Center, National Center for Child Health and Development, Japan SY-2(P-1)-3 Allergy prevention by microbial manipulation: are we ready? Speaker: Ting Fan Leung Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Symposium 3 p.536 Eosinophilic Gastrointestinal Disease (EGID) SY-3(M-1)-1 Pathogenesis of Eosinophilic Esophagitis (EoE) -how does the esophagus respond to allergens? Speaker: Glenn Furuta Department of Pediatrics, University of Colorado School of Medicine/Children's Hospital Colorado, USA SY-3(M-1)-2 Eosinophilic esophagitis what the allergist needs to know Speaker: Luc Biedermann Division of Gastroenterology & Hepatology, University Hospital Zurich, Switzerland SY-3(M-1)-3 Eosinophilic gastroenteritis in Japan Speaker: Yoshikazu Kinoshita Steel Memorial Hirohata Hospital, Japan Symposium 4 p.537 Chronic Rhinosinusitis and Upper Airway SY-4(E-1)-1 Chronic Rhinosinusitis (CRS) and the upper airway Speaker: Robert Schleimer Allergy and Immunology, Northwestern University Feinberg School of Medicine, USA SY-4(E-1)-2 What should a surgeon know about the phenotypes of chronic rhinosinusitis with nasal polyps Speaker: Luo Zhang Department of Otolaryngology Head and Neck Surgery, Capital Medical University, China SY-4(E-1)-3 Eosinophilic chronic rhinosinusitis Speaker: Shigeharu Fujieda Division of Otorhinolaryngology - Head & Neck Surgery, Department of Sensory and Locomotor Medicine, Faculty of Medical Science, University of Fukui, Japan DOUSBLQGG 470 Symposium 5 p.538 Contact Dermatitis SY-5(D-1)-1 The mechanical understanding of allergic contact dermatitis develops the in vitro method to detect sensitising chemicals Speaker: Setsuya Aiba Departmemt of Dermatology, Tohoku University Graduate School of Medicine, Japan SY-5(D-1)-2 Clinical variation of hair dye allergy Speaker: Jun Young Lee Department of Dermatology, The Catholic University of Korea, Seoul St Mary's Hospital, Republic of Korea SY-5(D-1)-3 Status of contact dermatitis and patch testing initiatives in Japan Speaker: Akiko Yagami Department of Allergology, Fujita Health University School of Medicine, Japan Symposium 6 p.539 Roles of ILCs SY-6(B-1)-1 The role of group 2 innate lymphoid cells in lung fibrosis Speaker: Kazuyo Moro Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University School of Medicine; Laboratory
Load more

Recommended publications
  • Results of Accepted Poster
    JSA/WAO Joint Congress 2020 Poster Session As of August 27, 2020 Abstract ID Session Number Abstract No. Seesion Abstract Title Country Efficacy and safety of levamisole as an immunodulator in the treatment of drug resistant 10004 Poster Session 1 PE1-1 Adult airway diseases India tuberculosis Clinical usefulness of serum and sputum YKL-40 in the management of asthma, ACO and 10057 Poster Session 1 PE1-2 Adult airway diseases Japan COPD Exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease 10203 Poster Session 1 PE1-3 Adult airway diseases Japan (COPD) overlap with distinct phenotypes 10289 Poster Session 1 PE1-4 Adult airway diseases Anti-allergy medication utilization in patients with Chronic Cough United States of America 10299 Poster Session 1 PE1-5 Adult airway diseases Burden of Persistent Chronic Cough in Adults in a Large Managed Care Organization United States of America Degree of skin moisture in allergic diseases varies according to complication of airway 10434 Poster Session 1 PE1-6 Adult airway diseases Japan diseases Baseline characteristics from Phase 3, randomized controlled trials (COUGH-1 and COUGH- 10538 Poster Session 1 PE1-7 Adult airway diseases United States of America 2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough Allergen avoidance clinical trial: correlation of symptom scores between 4 and 6 point 10711 Poster Session 1 PE1-8 Adult airway diseases Bulgaria scoring systems Comparison of diffusion capacity and bronchodilator responsiveness testing
    [Show full text]
  • High Histamine Concentrations in Human Sweat in Association with Type I Allergy to the Semi-Purified Sweat Antigen
    Allergology International 69 (2020) 307e309 Contents lists available at ScienceDirect Allergology International journal homepage: http://www.elsevier.com/locate/alit Letter to the Editor High histamine concentrations in human sweat in association with type I allergy to the semi-purified sweat antigen Dear Editor, To find bioactivity of histamine detected in sweat, we assessed concentrations of histamine to induce flare and wheal by the intra- Cholinergic urticaria (CholU) is characterized by pinpoint-sized dermal injection to healthy volunteers, and compared with hista- wheals with itching and/or stinging pain under sweating mine concentrations in sweat. Histamine concentrations at or conditions, including hot bathing, physical exercise and emotional higher than 100 ng/ml and 1000 ng/ml induced significant flare stress.1 The type I hypersensitivity to sweat is proposed to be and wheal formations (Fig. 2a,b). In four patients with CholU, a pa- involved in its pathogenesis.2 Indeed, more than 60% of patients tient with AD and three controls, sweat histamine concentrations with CholU shows immediate-type skin reactions upon intradermal were higher than the minimum concentration to induce flare injection of autologous sweat, and histamine release from baso- upon intradermal injection (100 ng/ml). In one patient with phils against the semi-purified sweat antigen in histamine release CholU and one control, they were high enough even for wheal assay (HRA).2,3 Histamine released from skin mast cells also plays induction (1000 ng/ml). an important role in the development of wheals in CholU.1 In this In this study, we demonstrated that levels of histamine con- study, we examined histamine concentrations in sweat of patients centration in sweat obtained from patients with CholU were with CholU to describe a role of sweat histamine in the wheal for- much higher than those in human plasma.
    [Show full text]
  • Ige-Mediated Hypersensitivity Against Human Sweat Antigen in Patients with Atopic Dermatitis
    Acta Derm Venereol 2002; 82: 335± 340 INVESTIGATIVE REPORT IgE-mediated Hypersensitivity Against Human Sweat Antigen in Patients with Atopic Dermatitis MICHIHIRO HIDE, TOSHIHIKO TANAKA, YUMI YAMAMURA, OSAMU KORO and SHOSO YAMAMOTO Department of Dermatology, Programs for Biomedical Research, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan Sweating aggravates itch in atopic dermatitis, but the a bath, is largely bene® cial to patients (1, 5), and mechanism is unclear. In this study, we examined the suggests the presence of aggravating factors on the skin involvement of type I hypersensitivity in the aggravation surface. On the other hand, immediate-type skin of atopic dermatitis by sweating. Skin tests with auto- reactions to human dander extracts (6, 7) and human logous sweat were positive in 56 of 66 patients (84.4%) sweat (8, 9) have been reported in patients with atopic with atopic dermatitis, but only in 3 of 27 healthy volun- dermatitis. Adachi & Aoki (9) showed the binding teers (11.1%). Sweat samples from both patients and activity of IgE antibody against sweat concentrate healthy volunteers induced varying degrees of histamine collected from a healthy volunteer in patients with release from basophils of patients with atopic dermatitis. atopic dermatitis. More recently, Valenta et al. (10) and However, the histamine release was impaired by removal Natter et al. (11) have identi® ed several intracellular of IgE on the basophils. Incubation of basophils with autoantigens for IgE antibodies in the sera of patients myeloma IgE before sensitization with serum of patients with severe skin manifestations of atopic dermatitis.
    [Show full text]
  • 10 Chronic Urticaria As an Autoimmune Disease
    10 Chronic Urticaria as an Autoimmune Disease Michihiro Hide, Malcolm W. Greaves Introduction Urticaria is conventionally classified as acute, intermittent and chronic (Grea- ves 2000a). Acute urticaria which frequently involves an IgE-mediated im- munological mechanism, is common, its causes often recognised by the patient, and will not be considered further. Intermittent urticaria – frequent bouts of unexplained urticaria at intervals of weeks or months – will be dis- cussed here on the same basis as ‘ordinary’ chronic urticaria. The latter is conventionally defined as the occurrence of daily or almost daily whealing for at least six weeks. The etiology of chronic urticaria is usually obscure. The different clinical varieties of chronic urticaria will be briefly considered here, and attention will be devoted to a newly emerged entity – autoimmune chronic urticaria, since establishing this diagnosis has conceptual, prognostic and the- rapeutic implications. Contact urticaria and angioedema without urticaria will not be dealt with in this account. Classification of Chronic Urticaria The clinical subtypes of chronic urticaria are illustrated in the pie-chart of Fig. 1. The frequency of these subtypes is based upon the authors’ experience at the St John’s Institute of Dermatology in UK. Whilst there may well be mi- nor differences, it is likely that the frequency distribution of these subtypes will be essentially similar in most centres in Europe and North America (Grea- ves 1995, 2000b). However, our experience suggests that the incidence of angioedema, especially that complicated by ordinary chronic urticaria is sub- stantially lower in Japan and south Asian countries (unpublished observation). 310 Michihiro Hide and Malcolm W.
    [Show full text]
  • A Case of Cold-Induced Cholinergic Urticaria Accompanied by Cholinergic Urticaria Showing a Positive Ice Cube Test
    Allergology International 69 (2020) 150e151 Contents lists available at ScienceDirect Allergology International journal homepage: http://www.elsevier.com/locate/alit Letter to the Editor A case of cold-induced cholinergic urticaria accompanied by cholinergic urticaria showing a positive ice cube test Dear Editor, eyelids, erythema of the face and generalized pruritic wheals, fol- lowed by sweating (Fig. 1A). The wheals disappeared spontane- Cholinergic urticaria (CholU) is a frequent form of inducible ur- ously within an hour. Results of a quantitative Sudomotor Axon ticaria provoked after sweating due to various stimuli that increase Reflex Test revealed a normal sweating function, and cholinergic the core body temperature, such as exercise, hot bathing, emotional urticaria with acquired anhidrosis or hypohidrosis was denied. In- stress and thermal environment.1 Its clinical features include itchy, tradermal injection of acetylcholine into the volar aspect of the pinpoint-sized wheals and surrounding erythema, and the symp- forearm showed numerous pin-point hives around the injection toms are often worse in hot summer weather. Although the precise site (Fig. 1B). In an autologous sweat skin test using her sweat mechanisms are not completely understood, IgE-mediated mast collected during sauna bathing, the result was positive for 100- cell activation and histamine release is extremely important in fold diluted sweat with wheal diameters of 6 Â 7 mm accompanied the pathogenesis of CholU. Patients with CholU frequently show by a flare reaction. The diagnosis of CholU with sweat hypersensi- an atopic background and have sweat allergy with specific IgE tivity was therefore made. against a protein from Malassezia globosa, a major allergen con- She also complained of developing wheals in cold environments tained in human sweat.2 Cold-induced CholU is a rare phenomenon without any sweating stimulus.
    [Show full text]
  • Exacerbating Factors of Itch in Atopic Dermatitis
    Allergology International xxx (2016) 1e6 Contents lists available at ScienceDirect Allergology International journal homepage: http://www.elsevier.com/locate/alit Invited review article Exacerbating factors of itch in atopic dermatitis * Hiroyuki Murota , Ichiro Katayama Department of Dermatology, Course of Integrated Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan article info abstract Article history: Atopic dermatitis (AD) displays different clinical symptoms, progress, and response to treatment during Received 12 September 2016 early infancy and after childhood. After the childhood period, itch appears first, followed by formation of Received in revised form well-circumscribed plaque or polymorphous dermatoses at the same site. When accompanied with 11 October 2016 dermatitis and dry skin, treatment of skin lesions should be prioritized. When itch appears first, disease Accepted 12 October 2016 history, such as causes and time of appearance of itch should be obtained by history taking. In many Available online xxx cases, itch increases in the evening when the sympathetic nerve activity decreased. Treatment is pro- vided considering that hypersensitivity to various external stimulations can cause itch. Heat and Keywords: Atopic dermatitis sweating are thought to especially exacerbate itch. Factors causing itch, such as cytokines and chemical Exacerbating factors messengers, also induce itch mainly by stimulating the nerve. Scratching further aggravates dermatitis. Itch Skin hypersensibility, where other non-itch senses, such as pain and heat, are felt as itch, sometimes Life rhythm occurs in AD. Abnormal elongation of the sensory nerve into the epidermis, as well as sensitizing of the Pruritus peripheral/central nerve, are possible causes of hypersensitivity, leading to itch. To control itch induced by environmental factors such as heat, treatment for dermatitis is given priority.
    [Show full text]
  • Sensitization Against Skin Resident Fungi Is Associated with Atopy In
    Altrichter et al. Clin Transl Allergy (2020) 10:18 https://doi.org/10.1186/s13601-020-00324-z Clinical and Translational Allergy RESEARCH Open Access Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients Sabine Altrichter1 , Pia Schumacher1, Ola Alraboni1, Yiyu Wang1, Makiko Hiragun2, Michihiro Hide2 and Marcus Maurer1* Abstract Background: Cholinergic urticaria (CholU) is a common type of chronic inducible urticaria, characterized by small itchy wheals that appear upon physical exercise or passive warming. Malassezia globosa, a skin resident fungus, has been identifed as an antigen that induces mast cell/basophil degranulation and wheal formation through specifc IgE, in Japanese patients with atopic dermatitis and CholU. In this study we aimed in assessing the rate of IgE sensiti- zations against skin resident fungi in European CholU patients. Methods: We assessed serum IgE levels to Malassezia furfur, Candida albicans and Trichophyton mentagrophytes using routine lab testing and Malassezia globosa using a newly established ELISA. We correlated the results to wheal forma- tion and other clinical features. Results: Four patients (of 30 tested) had elevated levels of IgE against Malassezia furfur and Candida albicans and two had elevated levels of IgE against Trichophyton mentagrophytes. Four sera (of 25 tested) had elevated levels of IgE to the Malassezia globosa antigen supMGL_1304. Sensitization to one skin fungus was highly correlated with sensitiza- tion to the other tested fungi. We saw highly signifcant correlations of sensitization to supMGL_1304 with wheal size in the autologous sweat skin test (r 0.7, P 0.002, n 19), the Erlangen atopy score (r 0.5, P 0.03, n 19), total s = = = s = = = IgE serum levels (rs 0.5, P 0.04, n 19) and a positive screen for IgE against common airborne/inhalant allergens s (sx1; r 0.54, P 0.02,= n =19).
    [Show full text]
  • A Descriptive Study of Naadi Thervu and Its Clinical Features Based on the Text “Sadhaga Naadi”
    A DESCRIPTIVE STUDY OF NAADI THERVU AND ITS CLINICAL FEATURES BASED ON THE TEXT “SADHAGA NAADI” DISSERTATION SUBMITTED BY Dr. S. PRANAV DHEENATHAYALAN (Reg.No.321615003) TO THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY CHENNAI – 32 For the Partial fulfillment for Award of the Degree of DOCTOR OF MEDICINE (SIDDHA) (Branch V – P.G. NOI NAADAL) DEPARTMENT OF NOI NADAL GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI – 627 002. OCTOBER - 2019 GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, PALAYAMKOTTAI, TIRUNELVELI - 627002, TAMIL NADU, INDIA. Ph: 0462-2572736/2572737/2582010 Fax: 0462 2582010 DECLARATION BY THE CANDIDATE I hereby declare that this dissertation entitled A DESCRIPTIVE STUDY OF NAADI THERVU AND ITS CLINICAL FEATURES BASED ON THE TEXT “SADHAGA NAADI” is a bonafide and genuine research work done by me under the guidance and supervision of Prof. Dr. R. Neelavathy, MD(s)., Ph.D., Post Graduate Department of Noi Naadal, Government Siddha Medical College and Hospital, Palayamkottai and the dissertation has not formed the basis for the award of any other Degree, Diploma, Fellowship or other similar title. Date : Place : Signature of the Candidate Dr. S. Pranav Dheenathayalan GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, PALAYAMKOTTAI, TIRUNELVELI - 627002, TAMIL NADU, INDIA. Ph: 0462-2572736/2572737/2582010 Fax: 0462 2582010 DECLARATION BY THE CANDIDATE I hereby declare that this dissertation entitled A DESCRIPTIVE STUDY OF NAADI THERVU AND ITS CLINICAL FEATURES BASED ON THE TEXT “SADHAGA NAADI” is a bonafide and genuine research work done by me under the guidance and supervision of Prof. Dr. S. Victoria, MD(s). , Post Graduate Department of Noi Naadal, Government Siddha Medical College and Hospital, Palayamkottai and the dissertation has not formed the basis for the award of any other Degree, Diploma, Fellowship or other similar title.
    [Show full text]
  • Ige Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases?
    antibodies Review IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases? Christophe Pellefigues INSERM UMRS1149—CNRS ERL8252, Team «Basophils and Mast cells in Immunopathology», Centre de recherche sur l’inflammation (CRI), Inflamex, DHU Fire, Université de Paris, 75018 Paris, France; Christophe.pellefi[email protected] Received: 5 August 2020; Accepted: 4 September 2020; Published: 8 September 2020 Abstract: Atopic dermatitis (AD) is a common skin disease affecting 20% of the population beginning usually before one year of age. It is associated with the emergence of allergen-specific IgE, but also with autoreactive IgE, whose function remain elusive. This review discusses current knowledge relevant to the mechanisms, which leads to the secretion of autoreactive IgE and to the potential function of these antibodies in AD. Multiple autoantigens have been described to elicit an IgE-dependent response in this context. This IgE autoimmunity starts in infancy and is associated with disease severity. Furthermore, the overall prevalence of autoreactive IgE to multiple auto-antigens is high in AD patients. IgE-antigen complexes can promote a facilitated antigen presentation, a skewing of the adaptive response toward type 2 immunity, and a chronic skin barrier dysfunction and inflammation in patients or AD models. In AD, skin barrier defects and the atopic immune environment facilitate allergen sensitization and the development of other IgE-mediated allergic diseases in a process called the atopic march. AD is also associated epidemiologically with several autoimmune diseases showing autoreactive IgE secretion. Thus, a potential outcome of IgE autoreactivity in AD could be the development of further autoimmune diseases. Keywords: atopic dermatitis; autoreactive IgE; IgE; autoimmunity; basophil 1.
    [Show full text]
  • Kenjiro Shoda 1902—1977
    Title Kenjiro Shoda 1902—1977 Author(s) Nagao, Hirosi Citation Osaka Journal of Mathematics. 15(1) P.1-P.4 Issue Date 1978 Text Version publisher URL https://doi.org/10.18910/7258 DOI 10.18910/7258 rights Note Osaka University Knowledge Archive : OUKA https://ir.library.osaka-u.ac.jp/ Osaka University KENJIRO SHODA KENJIRO SHODA 1902-1977 Kenjiro Shoda died of a heart attack on March 20, 1977 at the age of 75 as he drove with his family to Ashikaga to enjoy the view of plum blossoms. Since there had not been any danger signals, his unexpected death was a great shock to all who knew him. Kenjiro Shoda was born at Tatebayashi in Gunma Prefecture on February 25, 1902. He spent all of his school years in Tokyo except when he attended the Eighth National Senior High School at Nagoya. He was graduated in 1925 from the Department of Mathematics, Faculty of Science of Tokyo Imperial University. After spending one year at the graduate school of the same univer- sity, in 1926 he went to Germany for further study. While in Tokyo Imperial University he was a student of T. Takagi. At graduate school, he studied the group representation theory through works of G. Frobenius and I. Schur under the guidance of T. Takagi. The first year in Germany was spent at the University of Berlin where he studied under I. Schur. His first mathematical accomplishment, the beautiful result on matrices, was attained in this period. The following year, 1927, he moved on to the University of Gottingen where he attended the Emmy Noether's lectures on "the Hypercomplex Systems and Representation Theory*'.
    [Show full text]
  • Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment
    Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment Saunte, Ditte M.L.; Gaitanis, George; Hay, Roderick James Published in: Frontiers in Cellular and Infection Microbiology DOI: 10.3389/fcimb.2020.00112 Publication date: 2020 Document version Publisher's PDF, also known as Version of record Document license: CC BY Citation for published version (APA): Saunte, D. M. L., Gaitanis, G., & Hay, R. J. (2020). Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment. Frontiers in Cellular and Infection Microbiology, 10, [112]. https://doi.org/10.3389/fcimb.2020.00112 Download date: 24. sep.. 2021 REVIEW published: 20 March 2020 doi: 10.3389/fcimb.2020.00112 Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment Ditte M. L. Saunte 1,2*†, George Gaitanis 3,4†‡ and Roderick James Hay 5† 1 Department of Dermatology, Zealand University Hospital, Roskilde, Denmark, 2 Department of Clinical Medicine, Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark, 3 Department of Skin and Venereal Diseases, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece, 4 DELC Clinic, Biel/Bienne, Switzerland, 5 St. Johns Institute of Dermatology, Kings College London, London, United Kingdom Edited by: Yeasts of the genus, Malassezia, formerly known as Pityrosporum, are lipophilic yeasts, Salomé LeibundGut-Landmann, which are a part of the normal skin flora (microbiome). Malassezia colonize the human University of Zurich, Switzerland skin after birth and must therefore, as commensals, be normally tolerated by the Reviewed by: Peter Mayser, human immune system. The Malassezia yeasts also have a pathogenic potential where University of Giessen, Germany they can, under appropriate conditions, invade the stratum corneum and interact with Philipp Peter Bosshard, the host immune system, both directly but also through chemical mediators.
    [Show full text]
  • Pathogenesis of Cholinergic Urticaria in Relation to Sweating Toshinori Bito1, Yu Sawada2 and Yoshiki Tokura3
    Allergology International. 2012;61:539-544 ! DOI: 10.2332 allergolint.12-RAI-0485 REVIEW ARTICLE Review Series: Advances in Consensus, Pathogenesis and Treatment of Urticaria and Angioedema Pathogenesis of Cholinergic Urticaria in Relation to Sweating Toshinori Bito1, Yu Sawada2 and Yoshiki Tokura3 ABSTRACT Cholinergic urticaria (CU) has clinically characteristic features, and has been frequently described in the litera- ture. However, despite its comparatively old history, the pathogenesis and classification remains to be clarified. CU patients are occasionally complicated by anhidrosis and!or hypohidrosis. This reduced-sweat type should be included in the classification because the therapeutic approaches are different from the ordinary CU. It is also well-known that autologous sweat is involved in the occurrence of CU. More than half of CU patients may have sweat hypersensitivity. We attempt to classify CU and address the underlying mechanisms of CU based on the published data and our findings. The first step for classification of CU seems to discriminate the pres- ence or absence of hypersensitivity to autologous sweat. The second step is proposed to determine whether the patients can sweat normally or not. With these data, the patients could be categorized into three subtypes: (1) CU with sweat hypersensitivity; (2) CU with acquired anhidrosis and!or hypohidrosis; (3) idiopathic CU. The pathogenesis of each subtype is also discussed in this review. KEY WORDS acetylcholine, acetylcholine receptor, anhidrosis, hypohidrosis, sweat hypersensitivity choline. In fact, acetylcholine stimulation can elicit INTRODUCTION hives as seen in CU, suggesting that the etiology of Cholinergic urticaria (CU) is a rare condition, but its CU includes certain events that are triggered by a incidence might be higher than that expected by gen- cholinergic stimulus.
    [Show full text]